Medico Remedies Limited has submitted its integrated financials for the quarter and nine months ending December 31, 2024, following compliance with SEBI regulations.

The company’s financial results, reviewed and approved by the board, indicate that sales within India totaled ₹21,472.44 cr, while international sales were ₹38,842.90 cr.

The total revenue reported for the quarter stands at ₹39,914.37 cr.

Notably, the results reflect a strategic focus on expanding market reach, which can enhance revenue potential.

However, the lack of segment reporting may limit insights into performance across various divisions.

Investors should maintain a positive outlook while keeping an eye on future growth initiatives and market positioning.